Aemetis Q1 2025: Revenue at $8.1M, Net Loss Improves

Ticker: AMTX · Form: 10-Q · Filed: May 8, 2025 · CIK: 738214

Sentiment: neutral

Topics: earnings, financials, loss

TL;DR

Aemetis Q1 revenue $8.1M, net loss narrowed. Still losing money but improving.

AI Summary

Aemetis, Inc. reported its first quarter 2025 results, with total revenues of $8.125 million. The company's net loss for the quarter was $1.268 million, an improvement from the $1.004 million net loss in the same period last year. Operating expenses were $7.951 million, down from $5.917 million in Q1 2024.

Why It Matters

This filing provides insight into Aemetis' financial performance in early 2025, indicating revenue generation and changes in profitability which can affect investor confidence and future strategic decisions.

Risk Assessment

Risk Level: medium — The company continues to report net losses, indicating ongoing financial challenges despite revenue generation.

Key Numbers

Key Players & Entities

FAQ

What were Aemetis' total revenues for the first quarter of 2025?

Aemetis reported total revenues of $8,125 for the first quarter of 2025.

What was the net loss for Aemetis in Q1 2025?

The net loss for Aemetis in Q1 2025 was $1,268.

How does the Q1 2025 net loss compare to Q1 2024?

The Q1 2025 net loss of $1,268 is an improvement compared to the Q1 2024 net loss of $1,004.

What were the operating expenses for Aemetis in the first quarter of 2025?

Operating expenses for Aemetis in the first quarter of 2025 were $7,951.

What was the previous name of Aemetis, Inc.?

Aemetis, Inc. was formerly known as AE BIOFUELS, INC. and MARWICH II LTD.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding AEMETIS, INC (AMTX).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing